(NASDAQ:SYRE), WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases, today announced scientific presentations at the ACR Convergence Congress. “We are excited to share follow-up data out […]

Orna Therapeutics, a leading biotechnology company developing a proprietary pipeline ofin vivotherapies across a broad range of autoimmune and oncology indications, today announced an upcoming presentation at the American College of Rheumatology (ACR) Annual Meeting being held October 24-29, 2025, in Chicago, Illinois. This dataset is a broader update on Orna's lead program, ORN-252, as

Today, HoldCo Asset Management, LP (“HoldCo”), a Florida-based investment firm managing approximately $2.6 billion in regulatory assets under management, released a presentation previously provided to the Board of Directors of First Interstate BancSystem, Inc. on September 3, 2025 entitled “Buy Back Stock and Swear the Rest Off.” https://mma.prnewswire.com/media/2804352/HoldCo_FIBK_Presentation.pdf?p=pdfthumbnail The presentation may be found at the

American Axle & Manufacturing Holdings, Inc. (AAM), (NYSE: AXL) will hold a conference call to discuss third quarter financial results and other related matters at 10:00 a.m. ET on Friday, November 7, 2025. A press release announcing the results will be issued before the market opens on the same day and will be available at

Bybit, the world's second-largest cryptocurrency exchange by trading volume, announced a significant enhancement for its trading community, raising the daily withdrawal limits for VIP and institutional clients to as high as 60 million USDT. The upgrade, effective October 24, 2025 at 10:00 AM UTC, addresses the growing operational requirements of professional traders and institutional participants

— OPUSWAVE Imaging System combines OFDI and IVUS into a single catheter, providing significant potential to reduce procedural time and costs in treating coronary artery disease — DualView imaging catheter offers a 150mm maximum pullback length, a 2.6 Fr. imaging profile, 6 Fr. guide compatibility and a variable pullback speed of up to 40mm/second in

Groundbreaking results from two NECTAR trials to be presented atTCT 2025 Neurotronic, Inc., a developer of multi-organ denervation to treat complex cardiovascular and metabolic disease, announced today the upcoming presentations of the first clinical outcomes of Neuviant™ Multi‑organ Denervation (MDN – hepatic and renal denervation) in patients with both type 2 diabetes mellitus (T2DM) and

Ponce Financial Group, Inc. Reports Third Quarter 2025 Results GlobeNewswire October 24, 2025 NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) — Ponce Financial Group, Inc., (the “Company”) (NASDAQ: PDLB), the holding company for Ponce Bank, N.A. (the “Bank”), today announced results for the third quarter of 2025. Third Quarter 2025 Highlights (Compared to Prior Periods):

Vivakor to Present at ThinkEquity Investor Conference on October 30, 2025 GlobeNewswire October 24, 2025 Management to Discuss the Company's Highlights Including its Recently Closed $40 Million Credit Facility to Expand its Crude Oil Trading Platform Dallas, TX, Oct. 24, 2025 (GLOBE NEWSWIRE) — Vivakor, Inc. (Nasdaq: VIVK) (“Vivakor” or the “Company”), an integrated provider

OBOOK Holdings Inc. Expands U.S. Regulatory Footprint to 40 States with New Washington Money Transmitter License GlobeNewswire October 24, 2025 ARLINGTON, Va., Oct. 24, 2025 (GLOBE NEWSWIRE) — OBOOK Holdings Inc. (NASDAQ: OWLS) (“OBOOK” or the “Company”), a blockchain technology company operating as the OwlTing Group, today announced a major regulatory milestone following its successful